Since the increased motility and invasiveness of metastatic carcinomas directly correlates with the expression of certain pro-metastatic adhesion molecules [59], we next examined whether inhibition of UCH-L1 DUB activity will down-regulate established metastatic markers such as N-cadherin, β-catenin and CD44. This evidence concerns the gene CDH2 and metastatic carcinoma.